A University of Pennsylvania biotechnology company that aims to treat autoimmune diseases by reengineering cells within the ...

Seasonal flu-related hospitalizations and outpatient visits reached a 15-year high during the 2024-25 season, according to ...

An influenza vaccine candidate from Moderna showed promising results in a late-stage trial, bringing the drug maker one step ...

Some members of the scientific community have concern that they’re coming out of the COVID pandemic—exposure to the virus, ...

RNA-1010 demonstrated superior relative vaccine efficacy that was 26.6% (95% CI; 16.7%, 35.4%) higher than a licensed ...

Overall, the rate of death seven days after mRNA vaccinations has been lower than the background ... Your generous donation supports their work.

Researchers added virus-like features to mRNA vaccines. In mice, this vaccine caused stronger, longer-lasting immune ...

Researchers develop a self-regulating mRNA medicine that adjusts protein production based on disease-related signals.

A research team from The University of Osaka and the Institute of Science Tokyo has developed a class of mRNA medicines that ...

A more effective vaccine technology may be on the horizon. In a new study in mice, researchers from the University of ...

Our study progresses from the rational design of polyplex micelles to the mechanistic elucidation of mRNA degradation, revealing RNase infiltration—rather than carrier dissociation—as the ...